Literature DB >> 26707785

Magnetic Resonance Imaging May Be a Valuable Radiation-Free Technique for Lung Pathologies in Patients with Primary Immunodeficiency.

Sevket Arslan1, Necdet Poyraz2, Ramazan Ucar3, Mihrican Yesildag4, Ahmet Yesildag2, Ahmet Zafer Caliskaner3.   

Abstract

PURPOSE: In some primary immunodeficiency (PID) patients, especially in the subgroup with common variable immunodeficiency (CVID), radiosensitivity is a concern and avoidance of repeated radiation exposure has been recommended. To investigate the use of lung Magnetic resonance imaging (MRI) instead of Computed Tomography (CT) for the diagnosis and follow-up of various lesions in the lung parenchyma and airways, especially in PID patients in whom x-ray exposure should be limited.
METHODS: The study enrolled 23 patients with PID who underwent thorax CT within the last 3 months and/or who will undergo initial radiological assessment. Lung MRI was performed in all patients to compare the pulmonary findings with CT images.
RESULTS: MRI performance was weaker at detecting bronchiectasis extension, and a low concordance was found between MRI and CT in the assessment of the number of bronchial generations. CT better identified peripheral airway abnormalities, while CT and MRI gave similar results for detecting the presence and extension of consolidation, bullae, mucus plugging, bronchial wall thickening, bronchiectasis severity and nodules.
CONCLUSIONS: Despite the low spatial resolution, higher cost, and low availability, we suggest MRI as a possible radiation-free alternative to CT in selected patients with PID.

Entities:  

Keywords:  Primary immunodeficiency; computerized tomography; lung imaging; magnetic resonance imaging; radiosensitivity

Mesh:

Year:  2015        PMID: 26707785     DOI: 10.1007/s10875-015-0227-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

Review 1.  Immunodeficiency associated with DNA repair defects.

Authors:  A R Gennery; A J Cant; P A Jeggo
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

Review 2.  Pediatric Chest MR Imaging: Lung and Airways.

Authors:  Juan C Baez; Pierluigi Ciet; Robert Mulkern; Ravi T Seethamraju; Edward Y Lee
Journal:  Magn Reson Imaging Clin N Am       Date:  2015-05       Impact factor: 2.266

Review 3.  [Respiratory manifestations of common variable immunodeficiency in adults].

Authors:  J Cadranel; D Bouvry; M Wislez
Journal:  Rev Mal Respir       Date:  2003-02       Impact factor: 0.622

4.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

5.  Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function.

Authors:  Katerina Haidopoulou; Alistair Calder; Alison Jones; Adam Jaffe; Samatha Sonnappa
Journal:  Pediatr Pulmonol       Date:  2009-07

6.  Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions.

Authors:  Haidong Liu; Ying Liu; Tielian Yu; Ning Ye
Journal:  Eur Radiol       Date:  2009-10-28       Impact factor: 5.315

Review 7.  Primary immunodeficiencies.

Authors:  Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2009-12-29       Impact factor: 10.793

8.  Non invasive assessment of lung disease in ataxia telangiectasia by high-field magnetic resonance imaging.

Authors:  Silvia Montella; Carmine Mollica; Andrea Finocchi; Andrea Pession; Maria Cristina Pietrogrande; Antonino Trizzino; Giusy Ranucci; Marco Maglione; Giuliana Giardino; Marco Salvatore; Francesca Santamaria; Claudio Pignata
Journal:  J Clin Immunol       Date:  2013-08-24       Impact factor: 8.317

9.  Unique DNA repair gene variations and potential associations with the primary antibody deficiency syndromes IgAD and CVID.

Authors:  Steven M Offer; Qiang Pan-Hammarström; Lennart Hammarström; Reuben S Harris
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

10.  Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.

Authors:  Isabella Quinti; Annarosa Soresina; Giuseppe Spadaro; Silvana Martino; Simona Donnanno; Carlo Agostini; Pignata Claudio; Dammacco Franco; Anna Maria Pesce; Federica Borghese; Andrea Guerra; Roberto Rondelli; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.542

View more
  6 in total

1.  Magnetic Resonance Imaging of Lungs as a Radiation-Free Technique for Lung Pathologies in Immunodeficient patients.

Authors:  Kushaljit Singh Sodhi; Niranjan Khandelwal
Journal:  J Clin Immunol       Date:  2016-07-14       Impact factor: 8.317

2.  Otologic evaluation of patients with primary antibody deficiency.

Authors:  Giuseppe Magliulo; Giannicola Iannella; Guido Granata; Andrea Ciofalo; Benedetta Pasquariello; Diletta Angeletti; Fabiola La Marra; Isabella Quinti
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-02       Impact factor: 2.503

Review 3.  Chronic Lung Disease in Primary Antibody Deficiency: Diagnosis and Management.

Authors:  Paul J Maglione
Journal:  Immunol Allergy Clin North Am       Date:  2020-06-09       Impact factor: 3.479

4.  Diagnostic accuracy of 3-T lung magnetic resonance imaging in human immunodeficiency virus-positive children.

Authors:  Pratyaksha Rana; Kushaljit Singh Sodhi; Anmol Bhatia; Akshay Kumar Saxena; Deepti Suri; Surjit Singh
Journal:  Pediatr Radiol       Date:  2019-09-13

5.  Appearance of COVID-19 pneumonia on 1.5 T TrueFISP MRI.

Authors:  Judith Eva Spiro; Adrian Curta; Shiwa Mansournia; Constantin Arndt Marschner; Stefan Maurus; Ludwig Thomas Weckbach; Dennis Martin Hedderich; Julien Dinkel
Journal:  Radiol Bras       Date:  2021 Jul-Aug

Review 6.  Bronchiectasis in Primary Antibody Deficiencies: A Multidisciplinary Approach.

Authors:  Luke A Wall; Elizabeth L Wisner; Kevin S Gipson; Ricardo U Sorensen
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.